Circadian rhythm dysregulation in bipolar disorder

Current Opinion in Investigational Drugs

Volumn 11, Issue 7, 2010, Pages 779-787

  Westrich, Ligia ^a   Sprouse, Jeffrey ^a  

^a LUNDBECK RESEARCH USA   (United States)

Author keywords

Biological clock; bipolar disorder; circadian rhythm; desynchronization; entrainment; kinase; light:dark cycle; oscillator; period length

Indexed keywords

AGOMELATINE; CASEIN KINASE IDELTA; CASEIN KINASE IEPSILON; CRYPTOCHROME 1; CRYPTOCHROME 2; LITHIUM; PER1 PROTEIN; PER2 PROTEIN; PF 670462; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN BMAL1; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG; NEW DRUG;

BIPOLAR DISORDER; CIRCADIAN RHYTHM; DRUG HALF LIFE; DRUG MECHANISM; HUMAN; LIGHT DARK CYCLE; MAJOR DEPRESSION; MOLECULAR CLOCK; MOOD CHANGE; NONHUMAN; REVIEW; SUPRACHIASMATIC NUCLEUS; ANIMAL; BIOLOGICAL MODEL; CHRONOBIOLOGY DISORDERS; COMPLICATION; DRUG EFFECTS; PHYSIOLOGY;

ANIMALS; BIPOLAR DISORDER; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DRUGS, INVESTIGATIONAL; HUMANS; MODELS, BIOLOGICAL;

EID: 77954112466     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Kripke DF, Mullaney DJ, Atkinson M, Wolf S: Circadian rhythm disorders in manic-depressives. Biol Psychiatry (1978) 13(3): 335-351.
2. Moore RY, Lenn NJ: A retinohypothalamic projection in the rat. J Comp Neurol (1972) 146(1):1-14.
3. Antle MC, Silver R: Orchestrating time: Arrangements of the brain circadian clock. Trends Neurosci (2005) 28(3):145-151.
4. Buijs RM, Scheer FA, Kreier F, Yi C, Bos N, Goncharuk VD, Kalsbeek A: Organization of circadian functions: Interaction with the body. Prog Brain Res (2006) 153:341-360.
5. Stratmann M, Schibler U: Properties, entrainment, and physiological functions of mammalian peripheral oscillators. J Biol Rhythms (2006) 21(6):494-506.
6. Takahashi JS, Hong HK, Ko CH, McDearmon EL: The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat Rev Genet (2008) 9(10):764-775.
7. Wolkowitz OM, Burke H, Epel ES, Reus VI: Glucocorticoids. Mood, memory, and mechanisms. Ann NY Acad Sci (2009) 1179:19-40.
8. Harvey AG: Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation. Am J Psychiatry (2008) 165(7):820-829.
9. Bachman D, Rabins P: 'Sundowning' and other temporally associated agitation states in dementia patients. Annu Rev Med (2006) 57:499-511.
10. Campuzano A, Vilaplana J, Cambras T, Díez-Noguera A: Dissociation of the rat motor activity rhythm under T cycles shorter than 24 hours. Physiol Behav (1998) 63(2):171-176.
11. Schwartz MD, Wotus C, Liu T, Friesen WO, Borjigin J, Oda GA, de la Iglesia HO: Dissociation of circadian and light inhibition of melatonin release through forced desynchronization in the rat. Proc Natl Acad Sci USA (2009) 106(41):17540-17545.
12. Lee ML, Swanson BE, de la Iglesia HO: Circadian timing of REM sleep is coupled to an oscillator within the dorsomedial suprachiasmatic nucleus. Curr Biol (2009) 19(10):848-852.
13. McEachron DL, Kripke DF, Sharp FR, Lewy AJ, McClellan DE: Lithium effects on selected circadian rhythms in rats. Brain Res Bull (1985) 15(3):347-350.
14. Soria V, Urretavizcaya M: [Circadian rhythms and depression]. Actas Esp Psiquiatr (2009) 37(4):222-232.
15. McClung CA: Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther (2007) 114(2):222-232.
16. Harper DG, Stopa EG, Kuo-Leblanc V, McKee AC, Asayama K, Volicer L, Kowall N, Satlin A: Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. Brain (2008) 131(Pt 6):1609-1617.
17. Wu YH, Swaab DF: Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med (2007) 8(6):623-636.
18. Wehr TA, Sack D, Rosenthal N, Duncan W, Gillin JC: Circadian rhythm disturbances in manic-depressive illness. Fed Proc (1983) 42(11):2809-2814.
19. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E: Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry (1998) 43(11):822-828.
20. McEachron DL, Kripke DF, Wyborney VG: Lithium promotes entrainment of rats to long circadian light-dark cycles. Psychiatry Res (1981) 5(1):1-9.
21. Vitaterna MH, King DP, Chang AM, Kornhauser JM, Lowrey PL, McDonald JD, Dove WF, Pinto LH, Turek FW, Takahashi JS: Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science (1994) 264(5159):719-725.
22. Lopez-Molina L, Conquet F, Dubois-Dauphin M, Schibler U: The DBP gene is expressed according to a circadian rhythm in the suprachiasmatic nucleus and influences circadian behavior. EMBO J (1997) 16(22):6762-6771.
23. Franken P, Lopez-Molina L, Marcacci L, Schibler U, Tafti M: The transcription factor DBP affects circadian sleep consolidation and rhythmic EEG activity. J Neurosci (2000) 20(2):617-625.
24. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, Vitaterna MH et al: Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA (2007) 104(15):6406-6411.
25. Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, Rodd ZA, Paulus M, Geyer MA, Edenberg HJ, Glatt SJ et al: Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet (2008) 147B(2):134-166.
26. Benedetti F, Dallaspezia S, Fulgosi MC, Lorenzi C, Serretti A, Barbini B, Colombo C, Smeraldi E: Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet (2007) 144B(5):631-635.
27. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, Smeraldi E: A single nucleotide polymorphism in glycogen synthase kinase 3-β promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett (2004) 355(1-2):37-40. (Pubitemid 38077179)
28. Benedetti F, Dallaspezia S, Colombo C, Pirovano A, Marino E, Smeraldi E: A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neurosci Lett (2008) 445(2):184-187.
29. Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C, Smeraldi E: Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β -50 T/C SNP. Neurosci Lett (2005) 376(1):51-55.
30. McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, Biederman J, Mick E, Faraone SV, Niculescu AB, Tsuang MT: Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry (2009) 9:70.
31. Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, McMahon FJ, Gershon ES, Liu C: Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet (2008) 147B(7):1047-1055.
32. Kripke DF, Nievergelt CM, Joo E, Shekhtman T, Kelsoe JR: Circadian polymorphisms associated with affective disorders. J Circadian Rhythms (2009) 7:2.
33. Le-Niculescu H, Patel SD, Bhat M, Kuczenski R, Faraone SV, Tsuang MT, McMahon FJ, Schork NJ, Nurnberger JI Jr, Niculescu AB, 3rd: Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet B Neuropsychiatr Genet (2009) 150B(2):155-181.
34. Soria V, Martínez-Amorós E, Escaramís G, Valero J, Pérez-Egea R, García C, Gutiérrez-Zotes A, Puigdemont D, Bayés M, Crespo JM, Martorell L et al: Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology (2010) 35(6):1279-1289.
35. Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Okumura T, Tsunoka T, Inada T, Ozaki N et al: Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population. Eur Arch Psychiatry Clin Neurosci (2009) 259(5):293-297.
36. Wirz-Justice A: From the basic neuroscience of circadian clock function to light therapy for depression: On the emergence of chronotherapeutics. J Affect Disord (2009) 116(3):159-160.
37. Benedetti F, Barbini B, Fulgosi MC, Colombo C, Dallaspezia S, Pontiggia A, Smeraldi E: Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: Acute response and long-term remission rates. J Clin Psychiatry (2005) 66(12):1535-1540.
38. Terman M: Evolving applications of light therapy. Sleep Med Rev (2007) 11(6):497-507.
39. Benedetti F, Barbini B, Colombo C, Smeraldi E: Chronotherapeutics in a psychiatric ward. Sleep Med Rev (2007) 11(6):509-522.
40. Wirz-Justice A, Van den Hoofdakker RH: Sleep deprivation in depression: What do we know, where do we go? Biol Psychiatry (1999) 46(4):445-453.
41. Bunney JN, Potkin SG: Circadian abnormalities, molecular clock genes and chronobiological treatments in depression. Br Med Bull (2008) 86:23-32.
42. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, Gillin JC, Potkin SG, Bunney WE: Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry (2009) 66(3):298-301.
43. Yin L, Wang J, Klein PS, Lazar MA: Nuclear receptor Rev-erbα is a critical lithium-sensitive component of the circadian clock. Science (2006) 311(5763):1002-1005.
44. Sahar S, Zocchi L, Kinoshita C, Borrelli E, Sassone-Corsi P: Regulation of BMAL1 protein stability and circadian function by gsk3β -mediated phosphorylation. PLoS One (2010) 5(1):e8561.
45. Iwahana E, Akiyama M, Miyakawa K, Uchida A, Kasahara J, Fukunaga K, Hamada T, Shibata S: Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci (2004) 19(8):2281-2287.
46. Klemfuss H, Kripke DF: Antimanic drugs stabilize hamster circadian rhythms. Psychiatry Res (1995) 57(3):215-222.
47. Yang S, Van Dongen HP, Wang K, Berrettini W, Bućan M: Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry (2009) 14(2):143-155.
48. Pandey GN, Ren X, Rizavi HS, Dwivedi Y: Glycogen synthase kinase-3β in the platelets of patients with mood disorders: Effect of treatment. J Psychiatr Res (2010) 44(3):143-148.
49. Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E: A glycogen synthase kinase 3-β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett (2004) 368(2):123-126. (Pubitemid 39194855)
50. Serretti A, Benedetti F, Mandelli L, Calati R, Caneva B, Lorenzi C, Fontana V, Colombo C, Smeraldi E: Association between GSK-3β -50T/C polymorphism and personality and psychotic symptoms in mood disorders. Psychiatry Res (2008) 158(2): 132-140.
51. Vougogiannopoulou K, Ferandin Y, Bettayeb K, Myrianthopoulos V, Lozach O, Fan Y, Johnson CH, Magiatis P, Skaltsounis AL, Mikros E, Meijer L: Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period. J Med Chem (2008) 51(20):6421-6431.
52. Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG, Kay SA: A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3β. Proc Natl Acad Sci USA (2008) 105(52):20746-20751.
53. Badura L, Swanson T, Adamowicz W, Adams J, Cianfrogna J, Fisher K, Holland J, Kleiman R, Nelson F, Reynolds L, St Germain K et al: An inhibitor of casein kinase Iε induces phase delays in circadian rhythms under free-running and entrained conditions. J Pharmacol Exp Ther (2007) 322(2):730-738.
54. Sprouse J, Reynolds L, Swanson TA, Engwall M: Inhibition of casein kinase I ε/δ produces phase shifts in the circadian rhythms of cynomolgus monkeys. Psychopharmacology (Berl) (2009) 204(4):735-742.
55. Lee H, Chen R, Lee Y, Yoo S, Lee C: Essential roles of CKIS and CKI ε in the mammalian circadian clock. Proc Natl Acad Sci USA (2009) 106(50):21359-21364.
56. Etchegaray JP, Machida KK, Noton E, Constance CM, Dallmann R, Di Napoli MN, DeBruyne JP, Lambert CM, Yu EA, Reppert SM, Weaver DR: Casein kinase 1 δ regulates the pace of the mammalian circadian clock. Mol Cell Biol (2009) 29(14): 3853-3866.
57. Walton KM, Fisher K, Rubitski D, Marconi M, Meng QJ, Sládek M, Adams J, Bass M, Chandrasekaran R, Butler T, Griffor M et al: Selective inhibition of casein kinase 1 ε minimally alters circadian clock period. J Pharmacol Exp Ther (2009) 330(2): 430-439.
58. Sprouse J, Reynolds L, Kleiman R, Tate B, Swanson TA, Pickard GE: Chronic treatment with a selective inhibitor of casein kinase I δ/ε yields cumulative phase delays in circadian rhythms. Psychopharmacology (Berl) (2010) 210(4):569-576.
59. Calabrese JR, Guelfi JD, Perdrizet-Chevallier C: Agomelatine adjunctive therapy for acute bipolar depression: Preliminary open data. Bipolar Disord (2007) 9(6):628-635.
60. Kasper S, Hamon M: Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action. World J Biol Psychiatry (2009) 10(2): 117-126.
61. 2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol (2007) 10(5): 661-673.
62. 2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol (2002) 17(5):239-247.
63. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D: The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther (2003) 306(3):954-964.
64. Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW: A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood. Int Clin Psychopharmacol (2010) 25(3):132-142.
65. -/- mice to light. J Biol Rhythms (2008) 23(3):211-219.
66. Shen S, Spratt C, Sheward WJ, Kallo I, West K, Morrison CF, Coen CW, Marston HM, Harmar AJ: Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice. Proc Natl Acad Sci USA (2000) 97(21):11575-11580.
67. Vitaterna MH, Selby CP, Todo T, Niwa H, Thompson C, Fruechte EM, Hitomi K, Thresher RJ, Ishikawa T, Miyazaki J, Takahashi JS et al: Differential regulation of mammalian period genes and circadian rhythmicity by cryptochromes 1 and 2. Proc Natl Acad Sci USA (1999) 96(21):12114-12119.